Chids Mahadevan - Net Worth and Insider Trading
Chids Mahadevan Net Worth
The estimated net worth of Chids Mahadevan is at least $12,152 dollars as of 2024-12-12. Chids Mahadevan is the See Remarks of Applied Therapeutics Inc and owns about 9,800 shares of Applied Therapeutics Inc (APLT) stock worth over $12,152. Details can be seen in Chids Mahadevan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chids Mahadevan has not made any transactions after 2022-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chids Mahadevan
Chids Mahadevan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chids Mahadevan owns 1 companies in total, including Applied Therapeutics Inc (APLT) .
Click here to see the complete history of Chids Mahadevan’s form 4 insider trades.
Insider Ownership Summary of Chids Mahadevan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLT | Applied Therapeutics Inc | 2022-05-16 | Chief Accounting Officer |
Chids Mahadevan Latest Holdings Summary
Chids Mahadevan currently owns a total of 1 stock. Chids Mahadevan owns 9,800 shares of Applied Therapeutics Inc (APLT) as of May 16, 2022, with a value of $12,152.
Latest Holdings of Chids Mahadevan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLT | Applied Therapeutics Inc | 2022-05-16 | 9,800 | 1.24 | 12,152 |
Holding Weightings of Chids Mahadevan
Chids Mahadevan Form 4 Trading Tracker
According to the SEC Form 4 filings, Chids Mahadevan has made a total of 1 transactions in Applied Therapeutics Inc (APLT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Applied Therapeutics Inc is the sale of 905 shares on May 16, 2022, which brought Chids Mahadevan around $1,493.
Insider Trading History of Chids Mahadevan
- 1
Chids Mahadevan Trading Performance
Chids Mahadevan Ownership Network
Ownership Network List of Chids Mahadevan
Ownership Network Relation of Chids Mahadevan
Chids Mahadevan Owned Company Details
What does Applied Therapeutics Inc do?
Who are the key executives at Applied Therapeutics Inc?
Chids Mahadevan is the Chief Accounting Officer of Applied Therapeutics Inc. Other key executives at Applied Therapeutics Inc include Chief Medical Officer Riccardo Perfetti , director & 10 percent owner & President and CEO Shoshana Shendelman , and 10 percent owner Alexandria Real Estate Equities, Inc. .
Applied Therapeutics Inc (APLT) Insider Trades Summary
Over the past 18 months, Chids Mahadevan made no insider transaction in Applied Therapeutics Inc (APLT). Other recent insider transactions involving Applied Therapeutics Inc (APLT) include a net sale of 1,276,982 shares made by Shoshana Shendelman , a net sale of 168,003 shares made by Riccardo Perfetti , and a net sale of 875,000 shares made by Alexandria Real Estate Equities, Inc. .
In summary, during the past 3 months, insiders sold 0 shares of Applied Therapeutics Inc (APLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,438,778 shares of Applied Therapeutics Inc (APLT) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 2,408,778 shares.
Applied Therapeutics Inc (APLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Therapeutics Inc Insider Transactions
Chids Mahadevan Mailing Address
Above is the net worth, insider trading, and ownership report for Chids Mahadevan. You might contact Chids Mahadevan via mailing address: C/o Applied Therapeutics, Inc., 545 5th Avenue Suite 1400, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
